Skip to content

Screening of biomarkers in tears of patients with acute cerebrovascular diseases based on proteomics

Screening of biomarkers in tears of patients with acute cerebrovascular diseases based on proteomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019787
Enrollment
Unknown
Registered
2018-11-28
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute cerebrovascular diseases

Interventions

Gold Standard:Diagnosed acute cerebrovascular diseases patient
in&#32
tears&#32
of&#32
patients&#32
with&#32

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute cerebrovascular diseases within 72 hours of onset; 2. Aged 18 to 65 years old.

Exclusion criteria

Exclusion criteria: 1. Patients have ocular diseaseshistory of wearing contact lenses and LASIK surgery; 2. Having used any eyedrops 3 hours before collection of tears; 3. Pregnancy or lactation; 4. Abnormal liver and/or kidney function; 5. Tumor.

Design outcomes

Primary

MeasureTime frame
biomarker;

Countries

China

Contacts

Public ContactQing-Wu Yang

The Second Affiliated Hospital of Army Medical University

yangqwmlys@163.com+86 13688685763

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026